Regal Assets Analytics

FDA

FDA Creating New Investment Opportunities in BioTech Stocks

By |2019-03-07T16:04:02-05:00November 5th, 2018|Categories: Bill Langbein, Health Care Equipment & Services, Healthcare, Insights, Pharmaceutical & Biotechnology, Value Walk|Tags: , , , |

Because FDA marketing clearance to sell a drug or device [...]

SanaCurrents Introduction – Turn to the Biotech Experts to Maximize Your Returns

By |2019-05-03T11:54:55-04:00November 4th, 2018|Categories: Bill Langbein, Health Care Equipment & Services, Healthcare, Insights, Pharmaceutical & Biotechnology|Tags: , , , , , , |

Introducing SanaCurrents Introducing SanaCurrents, a research service for the serious [...]

Welcome to SanaCurrents

By |2018-12-04T12:07:49-05:00October 28th, 2018|Categories: Bill Langbein, Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents|Tags: , , , , , , |

Life science investing always has been a roller coaster ride, [...]

Sinovac Biotech: Court Documents Show CEO Bribed Chinese FDA, Buyout Offers Could Be in Jeopardy

By |2019-05-01T10:44:23-04:00December 21st, 2016|Categories: GeoTeam Articles, Healthcare, Insights, Pharmaceutical & Biotechnology, premium, Sector News|Tags: , , , , , , |

Summary Recently disclosed court documents show that Sinovac Biotech’s (NASDAQ: [...]

Repro Med – REPR – Shares Stable on Heels of 2016 Second Quarter Results

By |2016-09-26T16:48:37-04:00September 26th, 2016|Categories: GeoTeam Research, Health Care Equipment & Services, Healthcare, In Depth Research, Insights, Sector News, Spotlight Research|Tags: , , , |

Shares of Repro Med (OOTC:REPR) are little changed following the company's [...]